Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, according to a new survey. Professional guidelines say that when pulmonary ...

Pulmonary arterial hypertension causes the small lung arteries ... In the initial stages, symptoms of pulmonary hypertension ...

A new treatment, Sotatercept, for pulmonary arterial hypertension (PAH) has recently been approved by the MHRA ...

Unfortunately, clinical symptoms of PAH are unspecific and are late manifestations of the disease. [3] As in this case, dyspnea on exertion is often the leading clinical symptom; however ...

Keros Therapeutics said on Wednesday it would voluntarily halt testing of an experimental blood pressure treatment due to safety concerns during a mid-stage trial, sending its shares down 17% in ...

Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.